Mission Creek Capital Partners, Inc. Biogen Inc. Transaction History

Mission Creek Capital Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $187,826 - $282,725	-795 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $29,124 - $33,628	-110 Reduced 12.15%	795 $226,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $1,293 - $1,712	5 Added 0.56%	905 $242,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $18,819 - $23,872	-70 Reduced 7.22%	900 $285,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $213,458 - $294,947	970 New	970 $288,000

993

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mission Creek Capital Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Mission Creek Capital Partners, Inc. with notifications on news.